Mechanisms Underlying Vascular Endothelial Growth Factor Receptor Inhibition-Induced Hypertension: The HYPAZ Trial. (2021)

First Author: Mäki-Petäjä K

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.17863/cam.65323

Publication URI: https://www.repository.cam.ac.uk/handle/1810/318206

Type: Journal Article/Review